Literature DB >> 2782760

Chronic obstructive pulmonary disease mortality in six U.S. cities.

F E Speizer1, M E Fay, D W Dockery, B G Ferris.   

Abstract

Results are presented from a 9- to 12-yr mortality follow-up of 8,427 white adults in six U.S. cities between 25 and 74 yr of age at enrollment. Survival analyses were performed for all causes on 941 confirmed deaths, and for specific primary causes for the subset of 851 death with death certificates. Relative level of FEV1 compared with predicted was a strong predictor of sex-specific chronic obstructive pulmonary disease (COPD), cardiovascular (CV), and all-cause mortality, even after adjusting for age, respiratory symptoms, and smoking. Even in this relatively large cohort, the total number of respiratory deaths was small, and no trend in COPD mortality could be determined over the period of study.

Entities:  

Mesh:

Year:  1989        PMID: 2782760     DOI: 10.1164/ajrccm/140.3_Pt_2.S49

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  31 in total

1.  Chronic productive cough is associated with death in smokers with early COPD.

Authors:  Nirupama Putcha; M Bradley Drummond; John E Connett; Paul D Scanlon; Donald P Tashkin; Nadia N Hansel; Robert A Wise
Journal:  COPD       Date:  2013-10-15       Impact factor: 2.409

Review 2.  Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema.

Authors:  Barbara A Forey; Alison J Thornton; Peter N Lee
Journal:  BMC Pulm Med       Date:  2011-06-14       Impact factor: 3.317

3.  Morbidity and mortality associated with the restrictive spirometric pattern: a longitudinal study.

Authors:  Stefano Guerra; Duane L Sherrill; Claire Venker; Christina M Ceccato; Marilyn Halonen; Fernando D Martinez
Journal:  Thorax       Date:  2010-06       Impact factor: 9.139

4.  Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes.

Authors:  P Lange; J Nyboe; M Appleyard; G Jensen; P Schnohr
Journal:  Thorax       Date:  1990-08       Impact factor: 9.139

5.  Factors associated with abnormal spirometry among HIV-infected individuals.

Authors:  M Bradley Drummond; Laurence Huang; Philip T Diaz; Gregory D Kirk; Eric C Kleerup; Alison Morris; William Rom; Michael D Weiden; Enxu Zhao; Bruce Thompson; Kristina Crothers
Journal:  AIDS       Date:  2015-08-24       Impact factor: 4.177

6.  Both pulmonary and extra-pulmonary factors predict the development of disability in chronic obstructive pulmonary disease.

Authors:  Jonathan P Singer; Patricia P Katz; Carlos Iribarren; Theodore A Omachi; Gabriela Sanchez; Edward H Yelin; Miriam G Cisternas; Paul D Blanc
Journal:  Respiration       Date:  2012-06-09       Impact factor: 3.580

7.  Chronic Obstructive Pulmonary Disease Alters Immune Cell Composition and Immune Checkpoint Inhibitor Efficacy in Non-Small Cell Lung Cancer.

Authors:  Nicholas M Mark; Julia Kargl; Stephanie E Busch; Grace H Y Yang; Heather E Metz; Huajia Zhang; Jesse J Hubbard; Sudhakar N J Pipavath; David K Madtes; A McGarry Houghton
Journal:  Am J Respir Crit Care Med       Date:  2018-02-01       Impact factor: 21.405

Review 8.  NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets.

Authors:  Yixuan Zhang; Priya Murugesan; Kai Huang; Hua Cai
Journal:  Nat Rev Cardiol       Date:  2019-10-07       Impact factor: 32.419

Review 9.  Chronic bronchitis and chronic obstructive pulmonary disease.

Authors:  Victor Kim; Gerard J Criner
Journal:  Am J Respir Crit Care Med       Date:  2012-11-29       Impact factor: 21.405

10.  Behavioral anti-smoking trial in chronic obstructive pulmonary disease patients.

Authors:  T J Crowley; M J Macdonald; M I Walter
Journal:  Psychopharmacology (Berl)       Date:  1995-05       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.